Occupational allergic contact dermatitis from systemic drugs
- 10 August 2019
- journal article
- research article
- Published by Wiley in Contact Dermatitis
- Vol. 82 (1) , 24-30
Abstract
Background: Health‐care workers (HCWs) and professionals working in the pharmaceutical industry are at risk of developing occupational allergic contact dermatitis (OACD) from systemic drugs (or drug intermediates).Objectives: To study demographic characteristics and identify systemic drugs responsible for OACD in patients investigated for contact allergy during the period 2001‐2019.Methods: In the study period, 9780 patients were patch tested with the European baseline series, sometimes with additional series, and other relevant potential allergens. All patients with a positive patch‐test reaction to systemic medication exposed to at work were included for further analysis.Results: Of 1248 HCWs examined in our clinic, 201 suffered from OACD. In 26 (13%) dermatitis was caused by skin contact with a systemic drug: 19 nurses, five chemists working in the pharmaceutical industry, one physician, and one veterinarian. In total, 45 positive patch‐test reactions to 20 different systemic drugs were found, with tetrazepam (n = 11), ranitidine hydrochloride (n = 5), and zolpidem (n = 4) being the most frequent. Three pharmaceutical chemists were sensitized to a drug intermediate. The lesions were mostly localized on the hands, but often also on the face, as airborne dermatitis.Conclusion: As much as 13% of OACD in HCWs, diagnosed in our tertiary referral center, was attributable to systemic drugs, most frequently in nurses.Keywords
This publication has 30 references indexed in Scilit:
- Bridging the Gender Divide: Facilitating the Educational Path for Men in NursingJournal Of Nursing Education, 2017
- Occupational allergy to pharmaceutical productsCurrent Opinion in Allergy and Clinical Immunology, 2016
- The Role of the Skin Barrier in Occupational Skin Diseases2016
- European Society of Contact Dermatitis guideline for diagnostic patch testing – recommendations on best practiceContact Dermatitis, 2015
- An update on airborne contact dermatitis: 2007–2011Contact Dermatitis, 2013
- Airborne contact dermatitis to drugsAllergologia et Immunopathologia, 2012
- The Pharmaceutical and Cosmetic Industries2012
- Evidence-based guidelines: occupational contact dermatitis and urticariaOccupational Medicine, 2010
- Patients with airborne sensitization/contact dermatitis from budesonide‐containing aerosols ‘by proxy’Contact Dermatitis, 2009
- Occupational dermatoses in health care workers evaluated for suspected allergic contact dermatitisContact Dermatitis, 2008